Roche Holding AG (OTCMKTS:RHHVF – Get Free Report) shares were down 0.5% during trading on Tuesday . The stock traded as low as $390.97 and last traded at $414.1960. Approximately 377 shares were traded during mid-day trading, a decline of 98% from the average session volume of 16,003 shares. The stock had previously closed at $416.1160.
Roche Price Performance
The company has a 50-day simple moving average of $407.11 and a 200-day simple moving average of $420.39.
About Roche
Roche Holding AG, traded on the OTCMKTS under the symbol RHHVF, is a leading global healthcare company with two core business divisions: Pharmaceuticals and Diagnostics. The company focuses on developing innovative medicines and diagnostic tests that address serious diseases, driving advances in personalized healthcare and precision medicine.
In its Pharmaceuticals division, Roche pioneers targeted therapies across oncology, immunology, ophthalmology and neuroscience. Flagship products include monoclonal antibodies and small-molecule treatments such as Herceptin, Avastin and Actemra, which have become standards of care for cancer and autoimmune conditions.
Featured Articles
- Five stocks we like better than Roche
- NextEra’s Dominion Deal Could Put It at the Center of the AI Power Race
- Amazon Could Be About to Reap the Rewards of a Software Spending Boom
- Best Buy’s Turnaround Is Gaining Traction, But Wall Street Still Needs Proof
- AI Fears Hit Nebius Stock, But Has the Growth Thesis Changed?
Receive News & Ratings for Roche Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche and related companies with MarketBeat.com's FREE daily email newsletter.
